*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>A fixed-dose combination antiretroviral therapy integrating <strong>Efavirenz</strong>, <strong>Emtricitabine</strong>, and <strong>Tenofovir Disoproxil Fumarate</strong>. This formulation optimizes HIV-1 treatment via reverse transcriptase inhibition. Molecular formula: C<sub>21</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub> (TDF component). CAS No.: 197985-68-5.</p>
<h3>Application</h3>
<ul>
<li>HIV-1 infection management in adults and pediatric patients.</li>
<li>First-line therapy for treatment-naive populations globally.</li>
<li>Supply chain integration for generic pharmaceutical manufacturers.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe hepatic impairment; requires strict storage below 30°C. Monitor renal function and bone density during prolonged exposure. Avoid use with potent CYP3A4 inducers.</p>